Document is current

Any future updates will be listed below

Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System

Crossref DOI link: https://doi.org/10.1007/s11096-025-01914-2

Published Online: 2025-04-23

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark